These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Peña AS, Dolman KM, Bril H, Dekker W, Nauta JJ. Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451 [Abstract] [Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Kiliç ZM, Tunç B, Ayaz S, Filik L, Aktaş S, Parlak E, Ulker A. Turk J Gastroenterol; 2004 Dec 25; 15(4):238-42. PubMed ID: 16249978 [Abstract] [Full Text] [Related]
7. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Papo M, Quer JC, Pastor RM, García-Pardo G, Olona M, Prats E, Mirapeix E, Rodríguez R, Richart C. Med Clin (Barc); 1998 Jan 17; 110(1):11-5. PubMed ID: 9527980 [Abstract] [Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Papo M, Quer JC, Pastor RM, García-Pardo G, Prats E, Mirapeix E, Rodríguez R, Richart C. Am J Gastroenterol; 1996 Aug 17; 91(8):1512-5. PubMed ID: 8759652 [Abstract] [Full Text] [Related]
11. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Am J Gastroenterol; 2001 Feb 17; 96(2):449-54. PubMed ID: 11232689 [Abstract] [Full Text] [Related]
14. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Am J Gastroenterol; 2001 Mar 17; 96(3):730-4. PubMed ID: 11280542 [Abstract] [Full Text] [Related]
17. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Am J Gastroenterol; 2000 Jun 17; 95(6):1495-502. PubMed ID: 10894586 [Abstract] [Full Text] [Related]
18. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease]. García-Herola A, Nos P, Hoyos M, Hinojosa J, Molés JR, Pascual S, Bustamante M, Sánchez Cuenca JM, Carmona E, Ponce J, Berenguer J. Gastroenterol Hepatol; 1998 Apr 17; 21(4):169-73. PubMed ID: 9633176 [Abstract] [Full Text] [Related]
19. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Lamproye A, Belaiche J, Louis E, Salmon J, Mahieu P. Acta Gastroenterol Belg; 1994 Apr 17; 57(2):171-6. PubMed ID: 8053303 [Abstract] [Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, Nakagawa K, Tanaka S, Teranishi T, Hirata I, Katsu K. Am J Gastroenterol; 1999 May 17; 94(5):1304-12. PubMed ID: 10235211 [Abstract] [Full Text] [Related] Page: [Next] [New Search]